NCT05962801

Brief Summary

The goal of this controlled clinical trial is to investigate the impact of regular home use of Lumoral device as an adjunct treatment compared to non-surgical periodontitis treatment (NSPT) alone on biofilm removal and host response in Stage III and Grade C smoking periodontitis patients at 6 months.The main question aims to answer is: • Does regular use of dual-light photodynamic therapy benefit NSPT in Stage III and Grade C smoking periodontitis patients? 30 participants will be asked to use Lumoral device every night before performing oral hygiene for 10 minutes, while the other 30 patients will be asked to perform only oral hygiene. Both of these groups will receive NSPT and will be followed for 6 months from baseline.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

October 4, 2023

Status Verified

September 1, 2023

Enrollment Period

1.4 years

First QC Date

July 19, 2023

Last Update Submit

September 30, 2023

Conditions

Keywords

periodontitisperiodontal diseasesphotodynamic therapyphotothermal therapysmokingnon-surgical periodontitis therapy

Outcome Measures

Primary Outcomes (1)

  • Changes in bleeding on probing (BOP)

    Changes in the presence of bleeding when probing at 6 sites per tooth. It is evaluated dichotomously.

    baseline, 2 weeks, 2 months, 6 months

Secondary Outcomes (7)

  • Changes of pocket depths

    baseline, 2 months, 6 months

  • Changes in clinical attachment level

    baseline, 2 months, 6 months

  • Difference in the number of "closed" pockets

    baseline, 2 months, 6 months

  • a-MMP8 saliva concentration

    baseline, 2 weeks, 2 months, 6 months

  • Changes in Turetsky Modified Quigley-Hein Plaque Index (TMQHPI)

    baseline, 2 weeks, 2 months, 6 months

  • +2 more secondary outcomes

Study Arms (2)

Lumoral users

ACTIVE COMPARATOR

Use of Lumoral device and Lumorinse mouthwash once per day for 6 months and performance of oral hygiene twice per day for 6 months.

Device: Lumoral device, Lumorinse

Lumoral non-users

NO INTERVENTION

No use of Lumoral device and Lumorinse mouthwash. Performance of oral hygiene twice per day for 6 months.

Interventions

Regular use of dual-light photodynamic therapy at home

Lumoral users

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Periodontal disease Stage III and Grade C with at least 6 sites with probing depth (PD) and clinical attachment loss (CAL) ≥5 mm and bleeding on probing (BoP) ≥15 teeth
  • aged ≥35
  • Smokers smoking ≥10 cigarettes per day

You may not qualify if:

  • Patients allergic to indocyanine
  • Patients with active carious lesions
  • Need for prophylactic antimicrobial coverage
  • Scaling and root planing in the previous 6 months
  • Non-smoking status or smoking less than 10 cigarettes per day
  • Antimicrobial therapy in the previous 6 months
  • Immunomodifying conditions/ diseases (e.g. diabetes mellitus, rheumatoid arthritis, osteoporosis)
  • Long-term use of medication that could interfere with periodontal response (e.g. biphosphonates)
  • Pregnancy or lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dental School of Aristotle University of Thessaloniki

Thessaloniki, 54124, Greece

RECRUITING

Related Publications (9)

  • AlSarhan MA, Altammami MA, Alaqeely RS, AlEbdi A, Jasser RA, Otaibi DA, Oraini SA, Habib SR, Alqahtani L, Alduhaymi IS, Alrabiah DK, Alaradi M, Alyamani EJ. Short-term improvement of clinical parameters and microbial diversity in periodontitis patients following Indocyanine green-based antimicrobial photodynamic therapy: A randomized single-blind split-mouth cohort. Photodiagnosis Photodyn Ther. 2021 Sep;35:102349. doi: 10.1016/j.pdpdt.2021.102349. Epub 2021 May 24.

    PMID: 34033939BACKGROUND
  • Lahteenmaki H, Patila T, Raisanen IT, Kankuri E, Tervahartiala T, Sorsa T. Repeated Home-Applied Dual-Light Antibacterial Photodynamic Therapy Can Reduce Plaque Burden, Inflammation, and aMMP-8 in Peri-Implant Disease-A Pilot Study. Curr Issues Mol Biol. 2022 Mar 8;44(3):1273-1283. doi: 10.3390/cimb44030085.

    PMID: 35723308BACKGROUND
  • Trujiilo K, Raisanen IT, Sorsa T, Patila T. Repeated Daily Use of Dual-Light Antibacterial Photodynamic Therapy in Periodontal Disease-A Case Report. Dent J (Basel). 2022 Sep 1;10(9):163. doi: 10.3390/dj10090163.

    PMID: 36135158BACKGROUND
  • Alassiri S, Parnanen P, Rathnayake N, Johannsen G, Heikkinen AM, Lazzara R, van der Schoor P, van der Schoor JG, Tervahartiala T, Gieselmann D, Sorsa T. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases. Dis Markers. 2018 Aug 5;2018:1306396. doi: 10.1155/2018/1306396. eCollection 2018.

    PMID: 30154936BACKGROUND
  • Jansson H, Wahlin A, Johansson V, Akerman S, Lundegren N, Isberg PE, Norderyd O. Impact of periodontal disease experience on oral health-related quality of life. J Periodontol. 2014 Mar;85(3):438-45. doi: 10.1902/jop.2013.130188. Epub 2013 Jul 29.

    PMID: 23895254BACKGROUND
  • Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine C. J Periodontol. 1970 Jan;41(1):41-3. doi: 10.1902/jop.1970.41.41.41. No abstract available.

    PMID: 5264376BACKGROUND
  • Chambrone L, Wang HL, Romanos GE. Antimicrobial photodynamic therapy for the treatment of periodontitis and peri-implantitis: An American Academy of Periodontology best evidence review. J Periodontol. 2018 Jul;89(7):783-803. doi: 10.1902/jop.2017.170172.

    PMID: 30133749BACKGROUND
  • Pakarinen S, Saarela RKT, Valimaa H, Heikkinen AM, Kankuri E, Noponen M, Alapulli H, Tervahartiala T, Raisanen IT, Sorsa T, Patila T. Home-Applied Dual-Light Photodynamic Therapy in the Treatment of Stable Chronic Periodontitis (HOPE-CP)-Three-Month Interim Results. Dent J (Basel). 2022 Nov 2;10(11):206. doi: 10.3390/dj10110206.

    PMID: 36354651BACKGROUND
  • Vakaki C, Fragkioudakis I, Patila T, Sakellari D. Regular home use of dual-light photodynamic therapy as an adjunct to non-surgical periodontal treatment in smokers: a single-center randomized controlled clinical trial. Clin Oral Investig. 2025 Nov 6;29(12):553. doi: 10.1007/s00784-025-06600-1.

MeSH Terms

Conditions

PeriodontitisCigarette SmokingPeriodontal DiseasesSmoking

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesTobacco SmokingBehaviorTobacco Use

Study Officials

  • Dimitra Sakellari, Professor

    Aristotle University Of Thessaloniki

    STUDY DIRECTOR

Central Study Contacts

Chrysoula Vakaki, Postgraduate

CONTACT

Dimitra Sakellari, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 19, 2023

First Posted

July 27, 2023

Study Start

January 23, 2023

Primary Completion

June 1, 2024

Study Completion

September 1, 2024

Last Updated

October 4, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Patients' data will be recorded in the electronic patients' database of the Dental School of Aristotle University of Thessaloniki and only the researchers of this study will have access to them.

Locations